SIP sigma pharmaceuticals limited

citi downgrades

  1. 56,865 Posts.
    lightbulb Created with Sketch. 285
    A Citi analyst report said Sigma was struggling to compete and would likely sell assets if it could get the right price, but that the case for acquisition by potential suitor Sanofi-Aventis was "not compelling."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.